57 related articles for article (PubMed ID: 11241795)
1. NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia.
Ahuja HG; Popplewell L; Tcheurekdjian L; Slovak ML
Genes Chromosomes Cancer; 2001 Apr; 30(4):410-5. PubMed ID: 11241795
[TBL] [Abstract][Full Text] [Related]
2. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
3. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with NUP98::HOXA9 mimicking acute promyelocytic leukemia.
Lin E; Chen W
Blood; 2023 Nov; 142(21):1845. PubMed ID: 37995102
[No Abstract] [Full Text] [Related]
5. Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.
Mendes A; Jühlen R; Bousbata S; Fahrenkrog B
Cells; 2020 Jul; 9(7):. PubMed ID: 32664447
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia.
Spinler K; Hamilton M; Bajaj J; Shima Y; Diaz E; Kritzik M; Reya T
bioRxiv; 2023 Dec; ():. PubMed ID: 38234720
[TBL] [Abstract][Full Text] [Related]
7. A Recurrent Cryptic
Wang Q; Zhang L; Zhu MQ; Zeng Z; Fang BZ; Xie JD; Pan JL; Wu CX; Wu N; Zhang R; Chen SN; Dai HP
Front Oncol; 2021; 11():690218. PubMed ID: 34367969
[TBL] [Abstract][Full Text] [Related]
8. Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia.
K Bhanumathy K; Balagopal A; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Giambra V
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430292
[TBL] [Abstract][Full Text] [Related]
9. NUP214 in Leukemia: It's More than Transport.
Mendes A; Fahrenkrog B
Cells; 2019 Jan; 8(1):. PubMed ID: 30669574
[TBL] [Abstract][Full Text] [Related]
10. Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.
Matte-Martone C; Liu J; Zhou M; Chikina M; Green DR; Harty JT; Shlomchik WD
J Clin Invest; 2017 Jun; 127(7):2765-2776. PubMed ID: 28604385
[TBL] [Abstract][Full Text] [Related]
11. Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in
Yang J; Lyu X; Zhu X; Meng X; Zuo W; Ai H; Deng M
Oncol Lett; 2017 May; 13(5):3066-3070. PubMed ID: 28521413
[TBL] [Abstract][Full Text] [Related]
12. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia.
Hattori A; McSkimming D; Kannan N; Ito T
Leuk Res; 2017 Mar; 54():47-54. PubMed ID: 28107692
[TBL] [Abstract][Full Text] [Related]
13. Pvr expression regulators in equilibrium signal control and maintenance of Drosophila blood progenitors.
Mondal BC; Shim J; Evans CJ; Banerjee U
Elife; 2014 Sep; 3():e03626. PubMed ID: 25201876
[TBL] [Abstract][Full Text] [Related]
14. Does HOXA9 Gene Expression in Egyptian Chronic Myelogenous Leukemia Patients Affect Disease Progression? A Retrospective Cohort Study.
Mohamad Ismail MM; Manar MM
Turk J Haematol; 2013 Dec; 30(4):359-65. PubMed ID: 24385825
[TBL] [Abstract][Full Text] [Related]
15. Stem cell maintenance and disease progression in chronic myeloid leukemia.
Ito T
Int J Hematol; 2013 Dec; 98(6):641-7. PubMed ID: 23550022
[TBL] [Abstract][Full Text] [Related]
16. β-Arrestin2 mediates the initiation and progression of myeloid leukemia.
Fereshteh M; Ito T; Kovacs JJ; Zhao C; Kwon HY; Tornini V; Konuma T; Chen M; Lefkowitz RJ; Reya T
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12532-7. PubMed ID: 22773819
[TBL] [Abstract][Full Text] [Related]
17. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
Gough SM; Slape CI; Aplan PD
Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant.
Matte-Martone C; Venkatesan S; Tan HS; Athanasiadis I; Chang J; Pavisic J; Shlomchik WD
J Immunol; 2011 Aug; 187(4):1653-63. PubMed ID: 21768400
[TBL] [Abstract][Full Text] [Related]
19. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
[TBL] [Abstract][Full Text] [Related]
20. Imaging hematopoietic precursor division in real time.
Wu M; Kwon HY; Rattis F; Blum J; Zhao C; Ashkenazi R; Jackson TL; Gaiano N; Oliver T; Reya T
Cell Stem Cell; 2007 Nov; 1(5):541-54. PubMed ID: 18345353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
